G. Hillas

发表

Prophylactic cranial irradiation in non-small cell lung cancer patients: who might be the candidates?

M. Alchanatis, Charalampos Dimitropoulos, G. Hillas, 2011, Cancer management and research.

The role of induced sputum in asthma assessment

T. Tsaganos, S. Loukides, P. Bakakos, 2012 .

Vascular endothelial growth factor and cysteinyl leukotrienes in sputum supernatant of patients with asthma.

K. Kostikas, N. Koulouris, S. Loukides, 2013, Respiratory medicine.

Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered Questions

P. Steiropoulos, A. Papaioannou, G. Hillas, 2022, Journal of personalized medicine.

Dual Bronchodilator in the Era of Triple Therapy

N. Tzanakis, S. Loukides, N. Rovina, 2020, International journal of chronic obstructive pulmonary disease.

Glycated Hemoglobin (HbA1c) as a Predictor of Outcomes during Acute Exacerbations of Chronic Obstructive Pulmonary Disease

S. Loukides, S. Papiris, A. Papaioannou, 2021, COPD.

The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease

K. Souliotis, M. Borges, G. Hillas, 2020, Therapeutic advances in respiratory disease.

Increased levels of osteopontin in sputum supernatant in patients with COPD.

K. Kostikas, N. Koulouris, S. Loukides, 2012, Chest.

Levels of angiopoietins 1 and 2 in induced sputum supernatant in patients with COPD.

K. Kostikas, S. Loukides, S. Papiris, 2012, Cytokine.

The direct and indirect costs of managing chronic obstructive pulmonary disease in Greece

N. Tzanakis, K. Souliotis, T. Vassilakopoulos, 2017, International journal of chronic obstructive pulmonary disease.

Angiopoietins 1 and 2 in sputum supernatant of optimally treated asthmatics: the effect of smoking

K. Kostikas, N. Koulouris, S. Loukides, 2015, European journal of clinical investigation.

Activin A and follistatin in patients with asthma. Does severity make the difference?

K. Kostikas, N. Koulouris, S. Loukides, 2017, Respirology.

Predictors of future exacerbation risk in patients with asthma

K. Kostikas, N. Koulouris, S. Loukides, 2016, Postgraduate medicine.

Increased levels of osteopontin in sputum supernatant of smoking asthmatics.

K. Kostikas, N. Koulouris, S. Loukides, 2013, Cytokine.

Increased levels of osteopontin in sputum supernatant in severe refractory asthma

S. Loukides, E. Tseliou, S. Papiris, 2010, Thorax.

Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma.

C. Roussos, S. Loukides, E. Tseliou, 2010, Chest.

Experimental and investigational phosphodiesterase inhibitors in development for asthma

S. Loukides, P. Bakakos, G. Hillas, 2019, Expert opinion on investigational drugs.

Adenosine deaminase activity and its isoenzymes in the sputum of patients with pulmonary tuberculosis.

P. Bakakos, K. Dimakou, G. Hillas, 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Antioxidants and mucolytics in COPD management: when (if ever) and in whom?

S. Hussain, T. Vassilakopoulos, G. Hillas, 2013, Current drug targets.

Targeted anti-IL-13 therapies in asthma: current data and future perspectives

S. Loukides, P. Bakakos, G. Hillas, 2018, Expert opinion on investigational drugs.

The association between serum periostin and a type 2 helper airway composite index in optimally treated asthmatics.

K. Kostikas, N. Koulouris, S. Loukides, 2017, The journal of allergy and clinical immunology. In practice.

Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers

K. Kostikas, S. Loukides, S. Papiris, 2011, Respirology.

Sestrin 2 levels are associated with emphysematous phenotype of COPD

N. Koulouris, S. Loukides, A. Papaioannou, 2022, PloS one.

Blood eosinophils as predictor of outcomes in patients hospitalized for COPD exacerbations: a prospective observational study

K. Kostikas, S. Loukides, S. Papiris, 2021, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?

N. Koulouris, S. Loukides, Kazuhiro Ito, 2020, Journal of clinical medicine.

The role of non‐invasive modalities for assessing inflammation in patients with non‐cystic fibrosis bronchiectasis

S. Loukides, S. Tsikrika, S. Papiris, 2017, Cytokine.

Asthma‐chronic obstructive pulmonary disease overlap: Diagnostic stability and inflammatory characteristics

K. Kostikas, N. Koulouris, S. Loukides, 2019, Allergy.

Pulmonary and Respiratory Medicine: Open Access Factors Associated with the Quality of Life of Greek Patients with Chronic Obstructive Pulmonary Disease

N. Maniadakis, G. Kourlaba, G. Hillas, 2017 .

Carcinoembryonic antigen, neuron‐specific enolase and cytokeratin fragment 19 (CYFRA 21‐1) levels in induced sputum of lung cancer patients

P. Bakakos, K. Dimakou, G. Hillas, 2008, Scandinavian journal of clinical and laboratory investigation.

SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics

K. Kostikas, K. Gourgoulianis, K. Samitas, 2022, The Journal of Allergy and Clinical Immunology: In Practice.

Predictors of Mortality in Tocilizumab-Treated Severe COVID-19

I. Papanikolaou, Eleftherios Markatis, K. Dimakou, 2022, Vaccines.

Epidemiological characteristics and outcomes from 187 patients with COVID-19 admitted to 6 reference centers in Greece: an observational study during the first wave of the COVID-19 pandemic.

N. Koulouris, S. Loukides, A. Tzouvelekis, 2021, Advances in respiratory medicine.

Exhaled breath temperature in optimally treated asthmatics: severity and underlying mechanisms

K. Kostikas, N. Koulouris, S. Loukides, 2018, Journal of breath research.

Low penetrance of antibiotics in the epithelial lining fluid. Experience from the use of inhaled antibiotics in patients with non CF-bronchiectasis.

D. Bouros, T. Karampitsakos, E. Stavropoulou, 2019, Pulmonary pharmacology & therapeutics.

Device use errors among patients with asthma and COPD and the role of training: a real-life study

S. Loukides, S. Tsikrika, A. Papaioannou, 2021, Postgraduate medicine.

Diagnostic accuracy of T2 biomarkers for the prediction of airway eosinophilia in treated smoking asthmatic patients with loss of asthma control.

K. Kostikas, N. Koulouris, S. Loukides, 2019, The journal of allergy and clinical immunology. In practice.

Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers

M. Angelopoulou, M. Kyrtsonis, T. Vassilakopoulos, 2022, Medicina.

Survey and Biological Insights of Pemetrexed-Related Therapeutic Improvement in Mesothelioma: The Nancy Centre of Biological Resources' Mesothelioma Cohort

F. Galateau-Sallé, E. Vollmer, N. Martinet, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Capturing patient-centered outcomes using innovative technologies in adults with severe eosinophilic asthma on benralizumab: Τhe EMPOWAIR real-world study design

K. Kostikas, S. Loukides, E. Zervas, 2022, Pneumon.

Diagnostic Accuracy of Multiple D-Dimer Cutoff Thresholds and Other Clinically Applicable Biomarkers for the Detection and Radiographic Evaluation of Pulmonary Embolism

T. Karampitsakos, A. Tzouvelekis, L. Thanos, 2022, Advances in respiratory medicine.

Primary care and COVID-19: cutting the Gordian knot – the Greek experience and algorithm

K. Kostikas, S. Loukides, P. Bakakos, 2020, ERJ Open Research.

Updated simplified approach of pharmacological treatment of stable COPD: Do common co-morbidities have a role?

A. Papaioannou, K. Dimakou, G. Hillas, 2021, Postgraduate medicine.

Global initiative for chronic obstructive lung disease (GOLD) recommendations: strengths and concerns for future needs

S. Loukides, A. Papaioannou, G. Hillas, 2022, Postgraduate medicine.

Controlled Mechanical Ventilation Attenuates the Systemic Inflammation of Severe Chronic Obstructive Pulmonary Disease Exacerbations.

T. Vassilakopoulos, G. Hillas, Sofia Nikolakopoulou, 2016, American journal of respiratory and critical care medicine.

Act early, save lives: managing COVID-19 in Greece

K. Souliotis, G. Hillas, I. Gountas, 2020, medRxiv.

C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia

T. Vassilakopoulos, P. Bakakos, G. Hillas, 2009, European Respiratory Journal.

CRP and PCT as predictors of survival and septic shock in ventilator-associated pneumonia

T. Vassilakopoulos, P. Bakakos, G. Hillas, 2009 .

VEGF and IL-18 in induced sputum of lung cancer patients.

C. Roussos, S. Loukides, N. Rovina, 2011, Cytokine.

Biomarkers obtained by non-invasive methods in patients with COPD: where do we stand, what do we expect?

K. Kostikas, S. Loukides, P. Bakakos, 2009, Current medicinal chemistry.

Serum Angiopoietin-2 and CRP Levels During COPD Exacerbations

K. Kostikas, S. Loukides, D. Perrea, 2014, COPD.

Antibodies targeting the interleukin-5 signaling pathway used as add-on therapy for patients with severe eosinophilic asthma: a review of the mechanism of action, efficacy, and safety of the subcutaneously administered agents, mepolizumab and benralizumab

A. Papaioannou, G. Hillas, E. Fouka, 2020, Expert review of respiratory medicine.

Asthma with Fixed Airflow Obstruction: From Fixed to Personalized Approach

K. Dimakou, S. Vogli, G. Hillas, 2022, Journal of personalized medicine.

COPD definition by GOLD ( Global Initiative for Chronic Obstructive Lung Disease ) guidelines : 5 “ Chronic obstructive pulmonary disease

I. Tsiligianni, N. Tzanakis, G. Hillas, 2018 .

Managing comorbidities in COPD

I. Tsiligianni, N. Tzanakis, Nikolaos Tzanakis, 2015, International journal of chronic obstructive pulmonary disease.

Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype.

K. Kostikas, N. Koulouris, S. Loukides, 2015, Respiratory medicine.

Greek Guidelines for the Management of COPD, a Proposal of a Holistic Approach Based on the needs of the Greek Community

G. Stratakos, N. Koulouris, S. Loukides, 2022, Journal of personalized medicine.

Acute exacerbation of COPD: is it the “stroke of the lungs”?

N. Tzanakis, G. Hillas, F. Perlikos, 2016, International journal of chronic obstructive pulmonary disease.

Blood eosinophils in COPD: friend or foe?

S. Loukides, A. Papaioannou, P. Bakakos, 2021, Expert review of respiratory medicine.

The disparity of health facilities in an urban area discourages proposed treatment application in inoperable lung cancer patients

P. Bakakos, G. Hillas, F. Vlastos, 2010, Cancer management and research.

Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease

S. Loukides, N. Iacovidou, A. Chalkias, 2017, Heart Failure Reviews.

The disease burden of chronic obstructive pulmonary disease in Greece

N. Maniadakis, G. Kourlaba, T. Vassilakopoulos, 2016, International journal of chronic obstructive pulmonary disease.

Polymorphisms of GSTs in Lung Adenocarcinoma Patients Followed in the Context of a Biobank

N. Anagnostopoulos, N. Koulouris, N. Martinet, 2013 .

Thoracic endosonography (EBUS/EUS‐b) in the diagnosis of different intrathoracic diseases: A 4‐year experience at a single‐centre in Greece

E. Zervas, T. Karampitsakos, A. Tzouvelekis, 2020, International journal of clinical practice.

Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model

A. Tzouvelekis, K. Antoniou, N. Tzanakis, 2023, Frontiers in Medicine.

Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control

K. Kostikas, N. Koulouris, S. Loukides, 2014, Clinical and Translational Allergy.

Direct and Indirect Costs of Asthma Management in Greece: An Expert Panel Approach

S. Loukides, K. Souliotis, T. Vassilakopoulos, 2017, Front. Public Health.

ROSE: radiology, obstruction, symptoms and exposure – a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group

M. Miravitlles, A. Bossios, M. Martínez-García, 2021, ERJ Open Research.

Pharmacological treatment of stable COPD: need for a simplified approach

A. Papaioannou, K. Dimakou, G. Hillas, 2019, Postgraduate medicine.

The role of increased red cell distribution width as a negative prognostic marker in patients with COPD.

D. Bouros, T. Karampitsakos, A. Tzouvelekis, 2019, Pulmonary pharmacology & therapeutics.

Prospective evaluation for inhalation devices in greek patients with COPD and asthma: The PAIR study.

G. Stratakos, E. Zervas, D. Bouros, 2019, Pulmonary pharmacology & therapeutics.

Outpatient Management of COVID-19 Disease: A Holistic Patient-Centered Proposal Based on the Greek Experience

K. Kostikas, A. Liapikou, E. Tzortzaki, 2021, Journal of personalized medicine.

Cardiovascular Disease and Chronic Obstructive Pulmonary Disease: Adding a Third Dimension to the ABE Global Initiative for Chronic Obstructive Lung Disease 2023 Chronic Obstructive Pulmonary Disease Classification

K. Kostikas, G. Hillas, A. Gogali, 2023, American journal of respiratory and critical care medicine.

The Economic Burden of Chronic Obstructive Pulmonary Disease in Greece

N. Maniadakis, G. Kourlaba, T. Vassilakopoulos, 2018, Applied Health Economics and Health Policy.

Prophylactic cranial irradiation in non-small cell lung cancer patients: who might be the candidates?

M. Alchanatis, Charalampos Dimitropoulos, G. Hillas, 2011, Cancer Management and Research.

Emphysematous Phenotype is Characterized by Low Blood Eosinophils: A Cross-Sectional Study

K. Kostikas, N. Koulouris, S. Loukides, 2017, COPD.

Epidemiological characteristics, clinical features and outcomes of patients with COVID-19 admitted to seven reference centers across Greece: An observational study during the fourth and fifth waves of the COVID-19 pandemic

K. Kostikas, S. Loukides, Emmanouil Alevrakis, 2023, Pneumon.

Managing comorbidities in COPD

I. Tsiligianni, N. Tzanakis, G. Hillas, 2015, International journal of chronic obstructive pulmonary disease.

Serum Angiopoietin-2 and CRP Levels During COPD Exacerbations

K. Kostikas, S. Loukides, D. Perrea, 2014, COPD.

The disparity of health facilities in an urban area discourages proposed treatment application in inoperable lung cancer patients

P. Bakakos, G. Hillas, F. Vlastos, 2010 .

Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes

N. Koulouris, K. Kostikas, S. Loukides, 2017, Allergy.

Do Evolving Practices Improve Survival in Operated Lung Cancer Patients? A Biobank May Answer

P. Wild, S. Lacomme, J. Vignaud, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality

S. Loukides, Emmanouil Alevrakis, E. Koukaki, 2023, Journal of clinical medicine.